Indonesia vs Uzbekistan: New cases tested for RR-/MDR-TB
Indonesia
94.0%
in 2024
Uzbekistan
94.0%
in 2024
Indonesia rank
76th
Uzbekistan rank
76th
New cases tested for RR-/MDR-TB over time
- Indonesia
- Uzbekistan
How they compare
Indonesia currently reports 94.0% against 94.0% in Uzbekistan, a difference of 0.0%.
Across all 15 years both countries report, Uzbekistan has been ahead every year.
Indonesia ranks 76th and Uzbekistan ranks 76th of 192 countries.
Uzbekistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 12.3% | 82.2% | 69.9% | Uzbekistan |
| 2020s | 79.4% | 98.8% | 19.4% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Indonesia or Uzbekistan?
- Indonesia, at 94.0% against 94.0% in Uzbekistan as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Indonesia and Uzbekistan?
- 0.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Uzbekistan?
- 15 years are reported by both, from 2010 to 2024.
- How do Indonesia and Uzbekistan rank globally for new cases tested for rr-/mdr-tb?
- Indonesia ranks 76th and Uzbekistan ranks 76th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.